Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2000
09/12/2000US6117662 Respiratory nitrate reductase alpha subunit
09/12/2000US6117656 Cloned genes encoding IG-CD4 fusion proteins and the use thereof
09/12/2000US6117655 Nucleic acid encoding adhesion variants
09/12/2000US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents
09/12/2000US6117653 Hepatitis B surface antigen vaccine
09/12/2000US6117652 Production of proteins by cell culture
09/12/2000US6117650 Testing sample for defects heart muscle activity; coat well with nutrients, plate muscle cells, culture cells, insert test sample into culture, culture cells, monitor adjustment in cell size and release of atrial natriuretic protein
09/12/2000US6117645 Human LH-RH receptor expression cells and use thereof
09/12/2000US6117641 Assays and reagents for identifying anti-fungal agents and uses related thereto
09/12/2000US6117640 Recombinant vaccine made in E. coli against dengue virus
09/12/2000US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease
09/12/2000US6117633 Detecting nucleotide sequences coding antitumor protein; hyridizing sequences of normal and cancer cells, probing libraries with sequences, isolating and fragmenting clones, insertion in vectors, isolate specific nucleotide sequences
09/12/2000US6117632 Detection of protein sequences which transfer compounds across human and animal tissues; incubation of phage with tissue, recover transported phage, amplify, repeat process with recovered phage, detect transport protein sequences
09/12/2000US6117426 Human amine transporter polypeptide fragments
09/12/2000US6117425 Supplemented and unsupplemented tissue sealants, method of their production and use
09/12/2000US6117423 Highly purified species of human leukocyte interferon
09/12/2000US6117422 Genetic engineering
09/12/2000US6117421 Method for promoting cell growth and immunosuppression using chaperonin
09/12/2000CA2265217A1 Slm-1 and slm-2: novel sam68-like mammalian proteins
09/12/2000CA2158024C A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof
09/12/2000CA2051375C Process and compositions for the isolation of human relaxin
09/12/2000CA2029408C Antibiotic a/16686 recovery process
09/12/2000CA2021762C Antigens and methods therefor
09/12/2000CA2020209C Low viscosity, highly concentrated surfactant suspension
09/12/2000CA1341097C Factor viii binding domain of von willebrand factor
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/08/2000WO2000052478A1 Detection of mtoc disrupting substances
09/08/2000WO2000052467A1 Methods of determining altered ndpk functions
09/08/2000WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
09/08/2000WO2000052193A1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE
09/08/2000WO2000052186A1 Means and methods for fibroblast-like or macrophage-like cell transduction
09/08/2000WO2000052184A1 Anti-neoplastic compositions and uses thereof
09/08/2000WO2000052181A2 Gcn4-derived expression of heterologous coding sequences and different uses thereof
09/08/2000WO2000052179A2 Dna binding compound-mediated molecular switch system
09/08/2000WO2000052169A1 Method of modifying plant morphology, biochemistry and physiology ii
09/08/2000WO2000052167A1 Angiopoietin-related protein and nucleic acids
09/08/2000WO2000052166A1 Human suppressor of fused
09/08/2000WO2000052165A2 Compositions and methods for breast cancer therapy and diagnosis
09/08/2000WO2000052164A2 Potassium channel molecules and uses therefor
09/08/2000WO2000052163A1 Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer
09/08/2000WO2000052162A2 Eukaryotic peptide uptake system for transportation of enkephalins
09/08/2000WO2000052161A2 Leukocyte- and blood-associated proteins
09/08/2000WO2000052160A1 Human serpin proteins
09/08/2000WO2000052159A1 Methods and reagents for inhibiting proliferation of smooth muscle cells
09/08/2000WO2000052158A1 Methods and reagents for inhibiting angiogenesis
09/08/2000WO2000052157A1 Tumor-associated antigen
09/08/2000WO2000052156A1 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
09/08/2000WO2000052154A2 Methods and reagents for decreasing clinical reaction to allergy
09/08/2000WO2000052153A2 Method to identify ligands for orphan receptors
09/08/2000WO2000052151A2 Human secretory proteins
09/08/2000WO2000052148A2 Substances for controlling fertility
09/08/2000WO2000052144A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
09/08/2000WO2000052137A2 Plant ligand-gated ion channels
09/08/2000WO2000052057A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate
09/08/2000WO2000052056A2 Anti-plasmodium compositions and methods of use
09/08/2000WO2000052052A1 Collagen peptides modified by grafting mercapto functions, method for the production thereof and uses thereof as biomaterials
09/08/2000WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
09/08/2000WO2000052050A2 Homology models of the glucocorticoid receptor
09/08/2000WO2000052049A2 A method for purifying human growth hormone
09/08/2000WO2000052048A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
09/08/2000WO2000052047A2 Human dickkopf-related protein and nucleic acid molecules and uses therefor
09/08/2000WO2000052046A1 Immunomodulating glycopeptide
09/08/2000WO2000052045A2 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
09/08/2000WO2000052044A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
09/08/2000WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
09/08/2000WO2000052040A1 Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
09/08/2000WO2000052039A2 Lectomedin materials and methods
09/08/2000WO2000052038A1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers
09/08/2000WO2000052030A1 Rflat-1: a transcription factor that activates rantes gene expression
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000052026A1 IDENTIFICATION OF A cDNA ASSOCIATED WITH COMPENSATORY HYPERTROPHY IN RENAL TISSUE
09/08/2000WO2000052025A1 Q16
09/08/2000WO2000052024A1 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING HUMAN ORGANIC ANION TRANSPORTER 6(hOATP6) AND SCREENING METHODS THEREOF
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000051647A2 Animal model of allergies
09/08/2000WO2000051636A1 Modulators of fgl2 prothrombinase
09/08/2000WO2000051631A2 Pegylated alpha interferon for hiv therapy
09/08/2000WO2000036116A3 Plant catabolite repression genes
09/08/2000WO2000035407A3 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
09/08/2000WO2000034329A3 Differentiation signal
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000027873A3 Interleukin-2 binding protein from arthropods
09/08/2000WO2000027414A3 Inhibition of the formation of vascular hyperpermeability
09/08/2000WO2000023590A3 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION
09/08/2000WO2000023573A3 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
09/08/2000WO2000020622A9 Zinc finger peptide cleavage of nucleic acids
09/08/2000WO2000019883A3 Compositions and methods of disease diagnosis and therapy
09/08/2000WO2000018940A9 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof
09/08/2000WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof
09/08/2000WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines
09/08/2000WO2000014239A3 Thioredoxin h homologs
09/08/2000WO2000014205A9 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/08/2000WO2000012702A3 Human genes differentially expressed in colorectal cancer
09/08/2000WO2000012546A9 MAMMALIAN elk POTASSIUM CHANNEL GENES
09/08/2000WO2000009709A3 Proteases and associated proteins
09/08/2000WO2000009697A3 Pesticidal toxins and genes from bacillus laterosporus strains
09/08/2000WO2000004921A9 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine
09/08/2000WO2000000604A9 Methods and compositions for modulating spermatogenesis
09/08/2000WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
09/08/2000WO1999053961A9 Peptides for efficient gene transfer